Evaluation of the Differences in the Expression of Biogenic Amine-Related mRNAs and Proteins in Endometrioid Endometrial Cancer

被引:3
|
作者
Czerwinski, Michal [1 ,2 ]
Bednarska-Czerwinska, Anna [2 ,3 ]
Zmarzly, Nikola [3 ]
Boron, Dariusz [3 ,4 ,5 ]
Oplawski, Marcin [4 ]
Grabarek, Beniamin Oskar [3 ,4 ,5 ]
机构
[1] Amer Med Clin, PL-40600 Katowice, Poland
[2] Gynctr Fertil Clin, PL-40121 Katowice, Poland
[3] Univ Technol Katowice, Fac Med, Dept Histol Cytophysiol & Embryol, PL-41800 Zabrze, Poland
[4] Ludwik Rydygier Mem Specialized Hosp, Dept Gynecol & Obstet Gynecol Oncol, PL-31826 Krakow, Poland
[5] TOMMED Specjalisci Zdrowia, Dept Gynecol & Obstet, Fredry 22, PL-40662 Katowice, Poland
关键词
endometrial cancer; biogenic amines; histamine receptors; dopamine receptors; expression profile; HISTAMINE-RECEPTOR ANTAGONISTS; H1; RECEPTOR; GROWTH-FACTOR; UP-REGULATION; DOPAMINE; CARCINOGENESIS; TRANSCRIPTION; BREAST; H3;
D O I
10.3390/jcm10214872
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Biogenic amines, such as adrenaline, noradrenaline, histamine, dopamine, and serotonin are important neurotransmitters that also regulate cell viability. Their detection and analysis are helpful in the diagnosis of many diseases, including cancer. The aim of this study was to determine the expression profile of the biogenic amine-related genes and proteins in endometrioid endometrial cancer compared to the control group. The material consisted of endometrial tissue samples and whole blood collected from 30 endometrioid endometrial cancer patients and 30 cancer-free patients. The gene expression was determined by the mRNA microarrays and validated by qRT-PCR. Protein levels were determined in the serum by the enzyme-linked immunosorbent assay (ELISA). Overexpression of histamine H1-H3 receptors and early growth response 1 and silencing of calmodulin, the histamine H4 receptor, and the dopamine D5 receptor have been reported in endometrioid endometrial cancer. The obtained results indicate disturbances in the signaling activated by histamine and dopamine receptors, which could potentially contribute to the progression of endometrioid endometrial cancer.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] L1CAM Expression is Related to Non-Endometrioid Histology, and Prognostic for Poor Outcome in Endometrioid Endometrial Carcinoma
    Geels, Yvette P.
    Pijnenborg, Johanna M. A.
    Gordon, Bart B. M.
    Fogel, Mina
    Altevogt, Peter
    Masadah, Rina
    Bulten, Johan
    van Kempen, Leon C.
    Massuger, Leon F. A. G.
    PATHOLOGY & ONCOLOGY RESEARCH, 2016, 22 (04) : 863 - 868
  • [32] Lynch syndrome-related non-endometrioid endometrial cancer: analysis of outcomes
    Bogani, Giorgio
    Tibiletti, Maria Grazia
    Ricci, Maria Teresa
    Carnevali, Ileana
    Liberale, Viola
    Paolini, Biagio
    Milione, Massimo
    Vitellaro, Marco
    Murgia, Ferdinando
    Chiappa, Valentina
    Ditto, Antonino
    Ghezzi, Fabio
    Raspagliesi, Francesco
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (01) : 56 - 61
  • [33] The expression of stanniocalcin-1, estrogen receptor and progesterone receptor in endometrioid endometrial cancer
    Erkilinc, Gamze
    Yuceer, Ramazan Oguz
    Erdemoglu, Evrim
    Kaymak, Zuemruet Arda
    Darbas, Serife Mehtap
    Bozkurt, Kemal Kursat
    ciris, Ibrahim Metin
    TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2023, 20 (01) : 8 - 15
  • [34] Selection and validation of endogenous controls for microRNA expression studies in endometrioid endometrial cancer tissues
    Torres, Anna
    Torres, Kamil
    Wdowiak, Paulina
    Paszkowski, Tomasz
    Maciejewski, Ryszard
    GYNECOLOGIC ONCOLOGY, 2013, 130 (03) : 588 - 594
  • [35] Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer
    Zorn, KK
    Bonome, T
    Gangi, L
    Chandramouli, GVR
    Awtrey, CS
    Gardner, GJ
    Barrett, JC
    Boyd, J
    Birrer, MJ
    CLINICAL CANCER RESEARCH, 2005, 11 (18) : 6422 - 6430
  • [36] Expression of PTEN and β-Catenin and Their Relationship With Clinicopathological and Prognostic Factors in Endometrioid Type Endometrial Cancer
    Sal, Veysel
    Demirkiran, Fuat
    Erenel, Hakan
    Tokgozoglu, Nedim
    Kahramanoglu, Ilker
    Bese, Tugan
    Turan, Hasan
    Sofiyeva, Nigar
    Calay, Zerrin
    Arvas, Macit
    Guralp, Onur
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 (03) : 512 - 520
  • [37] Cyclin E Expression Correlates with Cancer-specific Survival in Endometrial Endometrioid Adenocarcinoma
    Santala, Simi
    Talvensaari-Mattila, Anne
    Soini, Ylermi
    Santala, Markku
    ANTICANCER RESEARCH, 2015, 35 (06) : 3393 - 3397
  • [38] Prediction of lymph node metastasis in patients with endometrioid endometrial cancer using expression microarray
    Bidus, MA
    Risinger, JI
    Chandramouli, GVR
    Dainty, LA
    Litzi, TJ
    Berchuck, A
    Barrett, JC
    Maxwell, GL
    CLINICAL CANCER RESEARCH, 2006, 12 (01) : 83 - 88
  • [39] Racial/ethnic differences in endometrioid endometrial cancer survival among cases identified through the National Cancer Database
    Beckmeyer-Borowko, Anna B.
    Peterson, Caryn E.
    Brewer, Katherine C.
    Otoo, Mary O.
    Davis, Faith G.
    Hoskins, Kent F.
    Joslin, Charlotte E.
    CANCER RESEARCH, 2016, 76
  • [40] Necrosis related HIF-1α expression predicts prognosis in patients with endometrioid endometrial carcinoma
    Laura MS Seeber
    Nicole Horrée
    Petra van der Groep
    Elsken van der Wall
    René HM Verheijen
    Paul J van Diest
    BMC Cancer, 10